Switzerland· 65673007
Entresto
A valsartan and sacubitril product containing sacubitrilum, valsartanum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Valsartan and sacubitril is registered in 15 of 19 countries.
Countries holding a registration under ATC C09DX04 (valsartan and sacubitril), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 9 of them publish a price we can compare per daily dose
Valsartan and sacubitril · ATC C09DX04
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- sacubitrilum, valsartanum
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- C09DX04
- ATC class
- Valsartan and sacubitril
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680656730075168 StkCHF 358
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
8 interactions on record for valsartan and sacubitril.
Graded by severity as the source publishes them — 8 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Valsartan and sacubitril · interactions on record
8 records
- 8 moderate
Most severe, free to view
- NitisinoneA16AX04moderate
- SimvastatinC10AA01moderate
- RosuvastatinC10AA07moderate
- Darunavir and cobicistatJ05AR14moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Valsartan and sacubitril in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSACUBITRIL/VALSARTAN ACCORDACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava
- United StatesENTRESTONovartis Pharmaceuticals Corporation
- NetherlandsAlbaliva 24 mg/26 mg, filmomhulde tablettenEgis Pharmaceuticals Plc
- SpainALBALIVA 24 MG/26 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGEgis Pharmaceuticals Plc.
- FinlandEntrestoAbacus Medicine A/S
- PolandAlbalivaEgis Pharmaceuticals PLC
- SwedenEntresto 15 mg/16 mg Granulat i kapsel avsedd att öppnasNovartis Europharm Limited
- IcelandEntrestoNovartis Europharm Limited*
Authorised across Europe · EMA
The same active substance is authorised in 31 EEA countries. Names it is sold under:
- Austria · Sabivalsax, Sacubitril/Valsartan Devatis
- Belgium · Sacubitril/Valsartan Eg, Sacubitril/Valsartan Hcs
- Bulgaria · Атрилесто, Валкубит
- Cyprus · Sacubitril/Valsartan Accord, Sacubitril/Valsartan Tad
- Czechia · Sacubitril/Valsartan Accord, Sacubitril/Valsartan Polpharma
- Germany · Sacubitril/Valsartan Accord, Sacubitril/Valsartan Al
- Denmark · Bitrisal, Lumivaxon
- Estonia · Culbista, Sacubitril/Valsartan Accord
- Spain · Bidcor, Sacubitrilo / Valsartán Cinfamed
- Finland · Lumivaxon, Sacubitril/Valsartan Accord
- France · Sacubitril / Valsartan Biogaran, Sacubitril/Valsartan Accord
- United Kingdom (Northern Ireland) · Sacubitril/Valsartan, Sacubitril/Valsartan Stada
- Greece · Bitrisal, Ensavalia
- Croatia · Atrilesto, Culbista
- Hungary · Sacubitril/Valsartan Gedeon Richter, Sacubitril/Valsartan Stada
- Ireland · Sacubitril/Valsartan Accord, Sacubitril/Valsartan Krka
- Iceland · Entresto, Neparvis
- Italy · Sacubitril E Valsartan Accord, Sacubitril E Valsartan Alter
- Liechtenstein · Entresto, Neparvis
- Lithuania · Culbista, Sacubitril/Valsartan Polpharma
- Luxembourg · Sacubitril/Valsartan Eg
- Latvia · Culbista, Sacubitril/Valsartan Gedeon Richter
- Malta · Sacubitril/Valsartan Axunio, Sacubitril/Valsartan Clonmel
- Netherlands · Atrilesto, Brazier
- Norway · Entresto, Neparvis
- Poland · Brazier, Culbista
- Portugal · Bidcor, Neprilin
- Romania · Sacubitril/Valsartan Dr. Reddy’s, Sacubitril/Valsartan Gedeon Richter
- Sweden · Sacubitril/Valsartan Accord, Sacubitril/Valsartan Axunio
- Slovenia · Sakubitril/Valsartan Galenika, Sakubitril/Valsartan Hcs
- Slovakia · Sacubitril/Valsartan Gedeon Richter, Sacubitril/Valsartan Polpharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d96e5cc8-528f-4744-bc3f-e0688494bda9 GET /v1/drugs/d96e5cc8-528f-4744-bc3f-e0688494bda9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "sacubitrilum 48.6 mg + valsartanum 51.4 mg",
"valid_from": "2024-03-01",
"limitations": "[{\"description\":\"<b>Herzinsuffizienz mit reduzierter Ejektionsfraktion (HFrEF)</b><br>\\nIn geeigneter Kombination mit anderen Therapien für Herzinsuffizienz (z.B. Betablocker, Diuretika und Mineralkortikoidantagonisten) für die Behandlung erwachsener Patienten mit systolischer Herzinsuffizienz der NYHA Klasse II, III oder IV, deren linksventrikuläre Auswurffraktion (LVEF) vor Behandlung mit Entresto ≤ 40% beträgt und welche mit einer stabilen Dosis eines Angiotensin Converting Enzym (ACE)-Hemmers oder Angiotensin Rezeptor-Blockers (ARBs) vorbehandelt worden sind.<br>\\n<br>\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2024-03-01\",\"validTo\":null}]",
"galenic_form": "Filmtabl 100 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2015-11-01",
"self_retention_pct": 10
}See everything about valsartan and sacubitril.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.